Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Ordinary Shares, no par value
-
Shares outstanding
-
86,723,804
-
Total 13F shares
-
686,488
-
Share change
-
+32,813
-
Total reported value
-
$4,006,000
-
Price per share
-
$5.84
-
Number of holders
-
15
-
Value change
-
-$9,740
-
Number of buys
-
10
-
Number of sells
-
9
Institutional Holders of Alpha Tau Medical Ltd. - Ordinary Shares, no par value (DRTS) as of Q3 2022
As of 30 Sep 2022,
Alpha Tau Medical Ltd. - Ordinary Shares, no par value (DRTS) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
686,488 shares.
The largest 10 holders included
FMR LLC, ETF MANAGERS GROUP, LLC, JPMORGAN CHASE & CO, CITIGROUP INC, Wealthspire Advisors, LLC, FRED ALGER MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, Phoenix Holdings Ltd., and MORGAN STANLEY.
This page lists
15
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.